Status epilepticus causes long-term NMDA receptor-dependent behavioral changes and cognitive deficits

Ann C. Rice, Candace L. Floyd, Bruce G Lyeth, Robert J. Hamm, Robert J. DeLorenzo

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Purpose: The role of N-methyl-D-aspartate (NMDA)-receptor activation on behavioral and cognitive changes after status epilepticus (SE) is unknown. In this study, behavioral and cognitive changes after SE were evaluated in the short and long term and in rats in which the NMDA receptor was inactivated during SE. Methods: Pilocarpine (350 mg/kg) was injected to induce SE. Inhibition of the NMDA receptor during SE was achieved with MK-801 (4 mg/kg). Seizure intensity during SE was monitored by electroencephalography (EEG). After SE, behavioral studies were performed to identify abnormal behavior by using behavioral tests adapted from Moser's functional observational battery. Cognitive changes were assessed by using the Morris Water Maze (MWM). Results: Pilocarpine-treated animals scored significantly higher on two of the behavioral tests: the Touch test and the Pick-Up test. These behavioral changes occurred very soon after SE, with the earliest changes observed 2 days after SE and persisting for the life of the animal. Inhibition of the NMDA receptor with MK-801 completely inhibited these behavioral changes under conditions that did not alter the duration of SE. In addition, pilocarpine- treated animals exhibited cognitive deficits as determined by using the MWM. Six weeks after SE, the animals displayed significantly longer latencies to locate the hidden platform on this test. The impaired performance on the MWM also occurred as early as 5 days after SE. These cognitive deficits were prevented in animals treated with MK-801 during SE. Conclusions: The results indicate that behavioral and cognitive changes occur soon after SE, are permanent, and are dependent on NMDA-receptor activation during SE. NMDA- receptor activation may play an important role in causing cognitive and behavioral morbidity after recovery from SE.

Original languageEnglish (US)
Pages (from-to)1148-1157
Number of pages10
JournalEpilepsia
Volume39
Issue number11
StatePublished - 1998

Fingerprint

Status Epilepticus
N-Methyl-D-Aspartate Receptors
Pilocarpine
Dizocilpine Maleate
Water
Touch

Keywords

  • Behavioral changes
  • Memory
  • NMDA receptor
  • Postseizure Behavioral Battery
  • Status epilepticus

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Rice, A. C., Floyd, C. L., Lyeth, B. G., Hamm, R. J., & DeLorenzo, R. J. (1998). Status epilepticus causes long-term NMDA receptor-dependent behavioral changes and cognitive deficits. Epilepsia, 39(11), 1148-1157.

Status epilepticus causes long-term NMDA receptor-dependent behavioral changes and cognitive deficits. / Rice, Ann C.; Floyd, Candace L.; Lyeth, Bruce G; Hamm, Robert J.; DeLorenzo, Robert J.

In: Epilepsia, Vol. 39, No. 11, 1998, p. 1148-1157.

Research output: Contribution to journalArticle

Rice, AC, Floyd, CL, Lyeth, BG, Hamm, RJ & DeLorenzo, RJ 1998, 'Status epilepticus causes long-term NMDA receptor-dependent behavioral changes and cognitive deficits', Epilepsia, vol. 39, no. 11, pp. 1148-1157.
Rice, Ann C. ; Floyd, Candace L. ; Lyeth, Bruce G ; Hamm, Robert J. ; DeLorenzo, Robert J. / Status epilepticus causes long-term NMDA receptor-dependent behavioral changes and cognitive deficits. In: Epilepsia. 1998 ; Vol. 39, No. 11. pp. 1148-1157.
@article{69a879719b004a20bd0bee32d81e75dc,
title = "Status epilepticus causes long-term NMDA receptor-dependent behavioral changes and cognitive deficits",
abstract = "Purpose: The role of N-methyl-D-aspartate (NMDA)-receptor activation on behavioral and cognitive changes after status epilepticus (SE) is unknown. In this study, behavioral and cognitive changes after SE were evaluated in the short and long term and in rats in which the NMDA receptor was inactivated during SE. Methods: Pilocarpine (350 mg/kg) was injected to induce SE. Inhibition of the NMDA receptor during SE was achieved with MK-801 (4 mg/kg). Seizure intensity during SE was monitored by electroencephalography (EEG). After SE, behavioral studies were performed to identify abnormal behavior by using behavioral tests adapted from Moser's functional observational battery. Cognitive changes were assessed by using the Morris Water Maze (MWM). Results: Pilocarpine-treated animals scored significantly higher on two of the behavioral tests: the Touch test and the Pick-Up test. These behavioral changes occurred very soon after SE, with the earliest changes observed 2 days after SE and persisting for the life of the animal. Inhibition of the NMDA receptor with MK-801 completely inhibited these behavioral changes under conditions that did not alter the duration of SE. In addition, pilocarpine- treated animals exhibited cognitive deficits as determined by using the MWM. Six weeks after SE, the animals displayed significantly longer latencies to locate the hidden platform on this test. The impaired performance on the MWM also occurred as early as 5 days after SE. These cognitive deficits were prevented in animals treated with MK-801 during SE. Conclusions: The results indicate that behavioral and cognitive changes occur soon after SE, are permanent, and are dependent on NMDA-receptor activation during SE. NMDA- receptor activation may play an important role in causing cognitive and behavioral morbidity after recovery from SE.",
keywords = "Behavioral changes, Memory, NMDA receptor, Postseizure Behavioral Battery, Status epilepticus",
author = "Rice, {Ann C.} and Floyd, {Candace L.} and Lyeth, {Bruce G} and Hamm, {Robert J.} and DeLorenzo, {Robert J.}",
year = "1998",
language = "English (US)",
volume = "39",
pages = "1148--1157",
journal = "Epilepsia",
issn = "0013-9580",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Status epilepticus causes long-term NMDA receptor-dependent behavioral changes and cognitive deficits

AU - Rice, Ann C.

AU - Floyd, Candace L.

AU - Lyeth, Bruce G

AU - Hamm, Robert J.

AU - DeLorenzo, Robert J.

PY - 1998

Y1 - 1998

N2 - Purpose: The role of N-methyl-D-aspartate (NMDA)-receptor activation on behavioral and cognitive changes after status epilepticus (SE) is unknown. In this study, behavioral and cognitive changes after SE were evaluated in the short and long term and in rats in which the NMDA receptor was inactivated during SE. Methods: Pilocarpine (350 mg/kg) was injected to induce SE. Inhibition of the NMDA receptor during SE was achieved with MK-801 (4 mg/kg). Seizure intensity during SE was monitored by electroencephalography (EEG). After SE, behavioral studies were performed to identify abnormal behavior by using behavioral tests adapted from Moser's functional observational battery. Cognitive changes were assessed by using the Morris Water Maze (MWM). Results: Pilocarpine-treated animals scored significantly higher on two of the behavioral tests: the Touch test and the Pick-Up test. These behavioral changes occurred very soon after SE, with the earliest changes observed 2 days after SE and persisting for the life of the animal. Inhibition of the NMDA receptor with MK-801 completely inhibited these behavioral changes under conditions that did not alter the duration of SE. In addition, pilocarpine- treated animals exhibited cognitive deficits as determined by using the MWM. Six weeks after SE, the animals displayed significantly longer latencies to locate the hidden platform on this test. The impaired performance on the MWM also occurred as early as 5 days after SE. These cognitive deficits were prevented in animals treated with MK-801 during SE. Conclusions: The results indicate that behavioral and cognitive changes occur soon after SE, are permanent, and are dependent on NMDA-receptor activation during SE. NMDA- receptor activation may play an important role in causing cognitive and behavioral morbidity after recovery from SE.

AB - Purpose: The role of N-methyl-D-aspartate (NMDA)-receptor activation on behavioral and cognitive changes after status epilepticus (SE) is unknown. In this study, behavioral and cognitive changes after SE were evaluated in the short and long term and in rats in which the NMDA receptor was inactivated during SE. Methods: Pilocarpine (350 mg/kg) was injected to induce SE. Inhibition of the NMDA receptor during SE was achieved with MK-801 (4 mg/kg). Seizure intensity during SE was monitored by electroencephalography (EEG). After SE, behavioral studies were performed to identify abnormal behavior by using behavioral tests adapted from Moser's functional observational battery. Cognitive changes were assessed by using the Morris Water Maze (MWM). Results: Pilocarpine-treated animals scored significantly higher on two of the behavioral tests: the Touch test and the Pick-Up test. These behavioral changes occurred very soon after SE, with the earliest changes observed 2 days after SE and persisting for the life of the animal. Inhibition of the NMDA receptor with MK-801 completely inhibited these behavioral changes under conditions that did not alter the duration of SE. In addition, pilocarpine- treated animals exhibited cognitive deficits as determined by using the MWM. Six weeks after SE, the animals displayed significantly longer latencies to locate the hidden platform on this test. The impaired performance on the MWM also occurred as early as 5 days after SE. These cognitive deficits were prevented in animals treated with MK-801 during SE. Conclusions: The results indicate that behavioral and cognitive changes occur soon after SE, are permanent, and are dependent on NMDA-receptor activation during SE. NMDA- receptor activation may play an important role in causing cognitive and behavioral morbidity after recovery from SE.

KW - Behavioral changes

KW - Memory

KW - NMDA receptor

KW - Postseizure Behavioral Battery

KW - Status epilepticus

UR - http://www.scopus.com/inward/record.url?scp=0031738370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031738370&partnerID=8YFLogxK

M3 - Article

C2 - 9821978

AN - SCOPUS:0031738370

VL - 39

SP - 1148

EP - 1157

JO - Epilepsia

JF - Epilepsia

SN - 0013-9580

IS - 11

ER -